Ochsner

Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung

Retrieved on: 
Tuesday, February 13, 2024
NCT, Lung, MD, Research and development, FDA, Food, Cancer, Ochsner, Metastasis, KRYS, Interleukin, Tumor microenvironment, Patient, Gene, Clinical trial, Disease, Suma, Pharmaceutical industry

PITTSBURGH, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for inhaled KB707 for the treatment of patients with solid tumors with pulmonary metastases that are relapsed or refractory to standard of care therapy.

Key Points: 
  • “The therapeutic benefits of cytokine therapy for the treatment of solid tumors have long been recognized, but difficult to harness due to toxicities when given systemically.
  • In January 2024, the FDA cleared an amendment to the Company’s Investigational New Drug application to evaluate inhaled KB707 in a clinical trial to treat patients with locally advanced or metastatic solid tumors of the lung.
  • In July 2023, the FDA granted intratumoral KB707 Fast Track Designation for the treatment of anti-programmed cell death protein-1 relapsed/refractory locally advanced or metastatic melanoma.
  • “We look forward to the first patient being dosed with inhaled KB707 later this year.”

Gayle Benson Makes Historic Donation for New Home for Ochsner Children's Hospital

Retrieved on: 
Friday, December 15, 2023
Human, Ochsner Medical Center, NICU, Cardiology, Gayle, Wayfinding, Hospital, Elective surgery, Patient, Multimedia, Ochsner Health System, Element, Movement, Caregiver, Health, Emotion, Child, News, Work, Nursing care plan, Family, Parent, Physician, Children's Hospital, Pelican, Operating, Travel, Nursing, Toy, Ochsner

NEW ORLEANS, Dec. 15, 2023 /PRNewswire/ -- Ochsner Health announces plans for The Gayle and Tom Benson Ochsner Children's Hospital, made possible through a transformational gift from Mrs. Gayle Benson.

Key Points: 
  • NEW ORLEANS, Dec. 15, 2023 /PRNewswire/ -- Ochsner Health announces plans for The Gayle and Tom Benson Ochsner Children's Hospital, made possible through a transformational gift from Mrs. Gayle Benson.
  • "I am truly humbled to announce today The Gayle and Tom Benson Ochsner Children's Hospital," said Gayle Benson, New Orleans Saints Owner and Pelicans Governor.
  • Ochsner has become a national healthcare leader and destination for patients seeking medical care in virtually every discipline.
  • The Gayle and Tom Benson Ochsner Children's Hospital is designed to have a child-friendly and welcoming atmosphere, with colorful and engaging decor, age-appropriate accommodations, and an efficient, easy-to-navigate layout.

Clinical AI Pioneer Aidoc Partners with Ochsner Health to Transform Healthcare Delivery

Retrieved on: 
Thursday, June 29, 2023
Data management, Communication, Partnership, Health care, Ochsner Health System, Population health, Gulf Coast of the United States, Organization, Hospital, Triage, MD, EHR, Patient safety, Patient, Algorithm, Ochsner, Digital, AI, Health, Quadruple, Automation, Medical device, Management, Nursing, Pharmaceutical industry, Aidoc

NEW YORK, June 29, 2023 /PRNewswire/ -- Aidoc today announced a transformative partnership with Ochsner Health, a large healthcare system headquartered in New Orleans, operating 46 hospitals and more than 370 health and urgent care centers across the Gulf South. This partnership unites the clinical excellence of Ochsner with the power of Aidoc's advanced AI solutions, creating an alliance that advances the way healthcare is delivered, experienced and optimized across Louisiana and the Gulf South region.

Key Points: 
  • With the addition of Aidoc's clinical AI solutions and enterprise-wide AI platform, aiOS™ , Ochsner is further empowering healthcare professionals and improving patient outcomes.
  • "In the ever-evolving healthcare landscape, our teams at Ochsner Health are dedicated to harnessing emerging technologies to achieve our goals.
  • Pioneering Solutions: As leaders in the digital health landscape, Ochsner and Aidoc are committed to pushing the boundaries of innovation.
  • With AI and digital health technologies, Ochsner continues its focus on creating a sustainable healthcare ecosystem that delivers value for all stakeholders.

Ochsner Health and MD Anderson Announce Partnership to Create Fully Integrated Cancer Program in Louisiana

Retrieved on: 
Thursday, June 22, 2023
Partnership, Education, U.S. News & World Report Best Hospitals Rankings, Ochsner Health System, Commission, American Society of Clinical Oncology, Therapy, Cancer, Hope, Head, Research, Monroe Dunaway Anderson, Prostate, Neck, MD Anderson Cancer Center, Lung, U.S. News & World Report, Social, Organization, Nose, Adrian Dixon, Hospital, Estate (law), Patient, National Accreditation Program for Rectal Cancer, Physician, Anderson, Accreditation, FACS, Nutritionist, Diagnosis, American College, Health, Society, News, Hematopoietic stem cell transplantation, Pharmaceutical industry, Nursing, Ochsner

NEW ORLEANS and HOUSTON, June 22, 2023 /PRNewswire/ -- Ochsner Health and The University of Texas MD Anderson Cancer Center today announced a partnership to create Ochsner MD Anderson Cancer Center in southeastern Louisiana. Cancer patients in the region now have access to cancer treatments that are among the most advanced in the nation. Through this collaboration, Ochsner is the first and only provider in Louisiana with a fully integrated cancer program based on MD Anderson's standards and treatment plans.

Key Points: 
  • "As part of our ongoing commitment to providing world-renowned cancer care close to home, Ochsner is thrilled to join forces with MD Anderson to offer groundbreaking research and innovative therapies not found anywhere else in our region," said Brian Moore, M.D., FACS, medical director, Ochsner MD Anderson Cancer Center.
  • "Our patients can be confident that they will receive an enhanced level of comprehensive cancer care through this partnership.
  • Each member of our select team of cancer physicians has been certified by MD Anderson to clinically practice as part of the co-branded Ochsner MD Anderson cancer program, and appointed physicians will become adjunct members of MD Anderson faculty."
  • Ochsner MD Anderson is dedicated to improving the health of our communities and committed to the prevention and early detection of cancer.

Xavier University of Louisiana and Ochsner Health Partner to Create College of Medicine and Pursue Health, Educational Equity

Retrieved on: 
Tuesday, January 17, 2023
Sisters of the Blessed Sacrament, Ochsner Health System, Ochsner, University, Student, College of Medicine, Education, COVID-19, Gulf Coast of the United States, Tomorrow, Historically black colleges and universities, University of Florida College of Medicine-Jacksonville, Human resources, Curriculum, College, MD, Health equity, Senior, FACP, Xavier University of Louisiana, Health, Sister, Partnership, History, Katharine Drexel, Workforce, Welbodi Partnership, Medicine, Xavier University, Health care, Provost, HBCU, African Americans, Multimedia, Physician, Human Resources for Health, Management, Pharmacy, Research

NEW ORLEANS, Jan. 17, 2023 /PRNewswire/ -- Xavier University of Louisiana (Xavier) and Ochsner Health (Ochsner) today announced an agreement to establish a joint College of Medicine. The two institutions will create a strong physician pipeline that addresses longstanding inequities within the nation's health care system and builds the health care workforce of the future. By anchoring their partnership with a College of Medicine, Xavier and Ochsner affirm their legacy of advancing health care excellence and education for the next generation, bringing new opportunities to marginalized populations in Louisiana and the United States.

Key Points: 
  • The Partnership Will Create a New, Standalone College of Medicine in New Orleans, Training the Health Care Professionals of Tomorrow
    NEW ORLEANS, Jan. 17, 2023 /PRNewswire/ -- Xavier University of Louisiana (Xavier) and Ochsner Health (Ochsner) today announced an agreement to establish a joint College of Medicine.
  • To launch the College of Medicine, Ochsner and Xavier will form a nonprofit corporation, create a new curriculum and use facilities, personnel, and administrative processes of both institutions.
  • The new College of Medicine will be governed by a board of directors nominated by Ochsner and Xavier, with each institution appointing an equal number of directors.
  • Ochsner Health and Xavier again forged partnerships to improve health equity through new graduate programs in health sciences and the establishment of the Ochsner Health and Xavier University Institute for Health Equity and Research (OXIHER) .

Positron Corporation Announces Plans for Clinical Study of its New “Affinity PET-CT 4D” Nuclear Imaging Device

Retrieved on: 
Tuesday, December 20, 2022
Ochsner Health System, Institutional review board, Cardiology, Record, GCP, Ochsner, Good, Trial of the century, Patient, Nuclear medicine, Molecular imaging, OTC, Certification, FDA, POSC, IRB, Positron Corporation, Biomedical Research, Affinity, Medical imaging, Positron

The clinical study is sponsored by Positron and will be conducted by Dr. Robert Bober, Director of Molecular Imaging and Nuclear Cardiology of Ochsner Health.

Key Points: 
  • The clinical study is sponsored by Positron and will be conducted by Dr. Robert Bober, Director of Molecular Imaging and Nuclear Cardiology of Ochsner Health.
  • Dr. Bober has furnished a plan for the clinical study to an Institutional Review Board (IRB), which reviews and monitors biomedical research involving human subjects in accordance with FDA regulations.
  • Performing such an extensive clinical study requires a comprehensive investigational plan, patient selection criteria, labeling, and monitoring with records and reports which adhere to Good Clinical Practices (GCP).
  • The study will provide empirical data necessary for proper representation of the system’s image quality, performance, and efficacy with  cardiac PET imaging agents.

Sutter Health Appoints Warner L. Thomas as Next CEO

Retrieved on: 
Tuesday, September 13, 2022
University, Trustee, Volunteering, U.S. News & World Report, Medicare Payment Advisory Commission, Medicare, Hospital, Business administration, Telehealth, News, Gulf Coast of the United States, Warner, Population, Sutter Health, American Hospital Association, No, Patient, Investment, Physician, Master of Business Administration, CEO, Technology, Health, American Medical Group Association, Ochsner Health System, New Hampshire College, Solution, Accounting, Leadership, Questrom School of Business, Hospitality Review, Board, Association, GLOBE, Congress, Council, Education, Pharmaceutical industry, Management, Health insurance, Medicine, Ochsner, Director

For the past 10 years, Thomas has served as the president and CEO of Ochsner Health.

Key Points: 
  • For the past 10 years, Thomas has served as the president and CEO of Ochsner Health.
  • After a comprehensive national search, we are thrilled to have found the right leader for the next chapter of Sutter Health.
  • Warner is a CEO grounded in Sutters community roots and values, said Gubby Barlow, chair of Sutter Healths Board of Directors.
  • Thomas will succeed Conforti, Sutter Healths chief operating officer who has been serving as interim CEO since January 2022.

Warner Thomas takes new role as President & CEO of Sutter Health, Pete November named Ochsner Health CEO

Retrieved on: 
Tuesday, September 13, 2022
Nursing, Health, Hospitals, Other Health, Managed Care, General Health, Adult, University, Trustee, Health, General counsel, Neuroscience, U.S. News & World Report, Alston & Bird, Patient, M2 High Speed Tractor, News, Gulf Coast of the United States, Warner, Connected, Growth, Partnership, Â, Sutter Health, Physician, Pediatrics, CEO, National, Ochsner Health System, Cardiology, Board of directors, Leadership, Liver, Board, Research, Hospital, Multimedia, Innovation, Connected health, Education, Management, Medicine, Science, Ochsner, Director, Accounting, Lead

The Ochsner Health Board has unanimously voted to appoint Pete November, Ochsner Healths current Executive Vice President and Chief Financial Officer, as Thomass successor.

Key Points: 
  • The Ochsner Health Board has unanimously voted to appoint Pete November, Ochsner Healths current Executive Vice President and Chief Financial Officer, as Thomass successor.
  • View the full release here: https://www.businesswire.com/news/home/20220913005486/en/
    Pete November (left) and Warner Thomas (right) (Photo: Business Wire)
    Since joining Ochsner in 1998, and assuming the role of President and CEO in 2012, Warner has been instrumental in our growth and success.
  • Leading Ochsner Health over the past 10 years will be one of the greatest accomplishments of my career, Thomas noted.
  • Pete is an exemplary leader who has a deep understanding of Ochsner Health, our patients and the communities we serve, said Wisdom.

The AJMC Institute for Value-Based Medicine Hosts “Population Health Innovations for a Healthy State” Event in New Orleans

Retrieved on: 
Wednesday, August 31, 2022
Partnership, IVBM, Pharmacist, University, FACP, Connected health, The American Journal of Managed Care, Health equity, Patient, MEDLINE, CEO, Innovation, Liver, News, Neuroscience, Gulf Coast of the United States, University of Queensland, Hilton New Orleans Riverside, Physician, Health, Pediatrics, Population health, American Journal of Men's Health, Quality of life, U.S. News & World Report, Hospital, Faculty, Health policy, Ochsner Health System, Medicine, GLOBE, Ochsner, Accountability, Connected, Population, Hilton New Orleans/St. Charles Avenue, American Journal, Education, LSU Health Sciences Center Shreveport, Nursing, Cardiology, MPH, Research, MD, Lead

The event, Population Health Innovations for a Healthy State, will be held in partnership with Ochsner Health at the Hilton New Orleans Riverside from 4:30-8:25 p.m. CT.

Key Points: 
  • The event, Population Health Innovations for a Healthy State, will be held in partnership with Ochsner Health at the Hilton New Orleans Riverside from 4:30-8:25 p.m. CT.
  • Ochsner Health is a perfect partner for our Louisiana event, as their Healthy State by 2030 initiative shares the common goal of advancing communities through population health.
  • The event will cover the following sessions:
    Welcome and Introduction: What is Healthy State by 2030?
  • Were excited to partner with AJMC to bring the IVBM series to New Orleans as we work to optimize health outcomes throughout the state and beyond.

OCHSNER HEALTH ANNOUNCES PARTNERSHIP WITH DR. JAMES ANDREWS AND ANDREWS MEDICINE

Retrieved on: 
Thursday, March 17, 2022
Joint Commission, Disease, Health, The Foundation for Young Australians, Ochsner, Catholic University of Lyon, Gulf Coast of the United States, Center of excellence, Elective surgery, Partnership, Rehabilitation, Leadership, Ochsner Health System, New Orleans Saints, Multimedia, University, LSU School of Music, Research, Certification, Tulane University School of Medicine, Sports medicine, View, MD, LLC, American Sports Medicine Institute, Center, Physician, Orthopedic surgery, Athlete, Sport, Patient, New, Gold Seal, Dentistry, Medicine, Medicine

NEW ORLEANS, March 17, 2022 /PRNewswire/ -- Ochsner Health and internationally-renowned orthopedic surgeon James R. Andrews, MD announced an exclusive five-year partnership to create The Ochsner Andrews Orthopaedics & Sports Medicine Institute. Building upon Ochsner's award-winning sports medicine and orthopedic programs, Dr. Andrews will bring his expertise and education platform, newly launched as Andrews Medicine, to strengthen the best-in-class care for patients and athletes across Louisiana and Mississippi.

Key Points: 
  • NEW ORLEANS, March 17, 2022 /PRNewswire/ -- Ochsner Health and internationally-renowned orthopedic surgeon James R. Andrews, MD announced an exclusive five-year partnership to create The Ochsner Andrews Orthopaedics & Sports Medicine Institute.
  • The Ochsner Andrews Orthopaedics & Sports Medicine Institute will work in consultation with Dr. Andrews to expand Ochsner's accredited orthopedic sports medicine fellowship program and to enhance Ochsner's physical therapy and sports performance protocols and offerings.
  • native, Dr. Andrews is a founding member of the Andrews Institute, a trademark of Andrews Medicine, LLC, in Pensacola, Fla., and a co-founder of the Andrews Sports Medicine & Orthopaedic Center in Birmingham, Ala., the American Sports Medicine Institute in Birmingham and the Andrews Research and Education Foundation in Pensacola.
  • To make an appointment with our highly trained Ochsner Andrews Orthopaedics & Sports Medicine Institute physicians and learn more about our award-winning program, please visit www.ochsner.org/orthopedics .